Press Release: Foundation for Women’s Cancer Shows Positive Impact of “Seed” Grants and Awards on Future of Gynecologic Cancer Research

Chicago, IL – March 1, 2011- In the current issue of Gynecologic Oncology, theFoundation for Women’s Cancer, formerly the Gynecologic Cancer Foundation, summarizes the successful results of its Research Grants and Awards Program.

To date, the Foundation has awarded 82 research grants totaling more than $3.8 million. Uniquely, and in a climate of limited federal support, the Foundation targets young investigators with the hope that “seed” grants will provide encouragement and financial support at a crucial point in career paths, eventually blossoming into more scientists dedicated to gynecologic cancer research.

The Foundation reports an excellent return on investment:

  • 94% of award recipients remain involved in clinical research;
  • $58,000,000 in extramural funding has been awarded as a result of the initial research grants totaling $2,500,000 — a 23-fold return;
  • 325 peer-reviewed publications can be attributed to the research begun during the original grant period.

The data was published as part of the Foundation for Women’s Cancer’s 20th anniversary celebration. Founded by the Society for Gynecologic Oncologists in 1991, the Foundation supports research, education and increasing public awareness about cancers unique to women.

Dr. Anil Sood, lead author of the article and recipient of a 2001 research award, said, “In addition to support for research, during the past twenty years, the Foundation for Women’s Cancer has touched the lives of countless women and their families as each in their own way faced a cancer diagnosis.”

“The Foundation for Women’s Cancer is proud of its success in supporting crucial research and knowledge of reproductive cancers,” said David M. Gershenson, M.D., Foundation Chair. “As we celebrate our 20th anniversary, our strong, straightforward new name also signals our commitment to expand outreach to women not yet diagnosed with a gynecologic cancer, to alert them to methods of early detection and prevention of these often-overlooked cancers.”

On November 6th, 2011, the Foundation for Women’s Cancer will hold its second National Race to End Women’s Cancer in Washington, D.C., part of a weekend of events to raise awareness about these cancers. For more information and to register, visit the Foundation for Women’s Cancer Web site.

The Foundation for Women’s Cancer is a non-profit organization dedicated to funding research and training, and ensuring education and public awareness of gynecologic cancer prevention, early detection and optimal treatment.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.